Search the Newsreel

177,782 Shares in HA Sustainable Infrastructure Capital, Inc. $HASI Acquired by Avalon Trust Co

Avalon Trust Co recently acquired 177,782 shares of HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) for approximately $6.94 million, representing about 0.14% of the company. Other institutional investors also adjusted their holdings in the real estate investment trust, which specializes in financing climate change solutions. …

Bellars Harris Wealth Management LLC Invests $9.15 Million in Snap-On Incorporated $SNA

Bellars Harris Wealth Management LLC initiated a new position in Snap-On Incorporated (NYSE:SNA) during Q2, purchasing 22,730 shares valued at approximately $9.15 million, making it their 20th largest holding. Several other institutional investors also adjusted their stakes in Snap-On. The company recently reported earnings …

Mineralys Therapeutics, Inc. $MLYS Shares Bought by Bank of America Corp DE

Apple Inc. $AAPL is Allen Capital Group LLC's 7th Largest Position

Allen Capital Group LLC increased its stake in Apple Inc. ($AAPL) by 2.8% in the first quarter, making Apple its seventh largest holding. Other institutional investors have also adjusted their positions in Apple. The article also provides analyst ratings, insider transaction details, recent news …

Portillo's, Wingstop, Papa John's, and Sweetgreen Stocks Trade Up, What You Need To Know

Portillo's, Wingstop, Papa John's, and Sweetgreen Stocks Trade Up, What You Need To Know What Happened? A number of stocks jumped in the afternoon session after a government report indicated a cooling in wholesale food inflation, a key cost for the industry. The U.S. …

Singapore Telecommunications (SGX:Z74) Could Be 53% Undervalued After Mixed Q1 Earnings

NAPCO Security Technologies, Inc. (NASDAQ:NSSC) Receives Average Rating of "Moderate Buy" from Analysts

NAPCO Security Technologies (NASDAQ: NSSC) has received an average rating of "Moderate Buy" from eight analysts, with six recommending a buy and two a hold. The average 12-month price target is $48.67, indicating potential upside from its current $38.32. Recent analyst actions include TD …

Applied Digital Corporation (NASDAQ:APLD) Receives Average Recommendation of "Moderate Buy" from Brokerages

Applied Digital Corporation (NASDAQ:APLD) has received an average "Moderate Buy" recommendation from brokerages, with an average 12-month price target of $68.15. Despite a significant year-over-year revenue increase of 406.3%, the company missed EPS estimates, reporting a loss of $0.39 against an expected loss of …

Wix, AppLovin, Manhattan Associates, Strategy, and Oracle Shares Skyrocket, What You Need To Know

Wix, AppLovin, Manhattan Associates, Strategy, and Oracle Shares Skyrocket, What You Need To Know What Happened? A number of stocks jumped in the afternoon session after the Bureau of Labor Statistics reported that the July Producer Price Index was completely flat month-over-month—coming in below …

MMI|Marcus & Millichap Inc|Price:31.580|Chg%:-0.175

Wall Street Zen Upgrades Avalo Therapeutics (NASDAQ:AVTX) to Hold

Wall Street Zen has upgraded Avalo Therapeutics (NASDAQ:AVTX) from a "sell" to a "hold" rating, though the consensus among other analysts remains a "Moderate Buy" with an average price target of $45.10. The company reported a quarterly loss of $0.83 per share, missing estimates. …

Atara Biotherapeutics (NASDAQ:ATRA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen has upgraded Atara Biotherapeutics (NASDAQ:ATRA) from "Sell" to "Hold," reflecting an average "Hold" consensus among analysts with an average price target of $9.50. Despite the upgrade, ATRA shares opened down 4.9% at $8.09, with the company reporting a quarterly loss of …

AppLovin (APP) Is Down 9.0% After Mixed Q2 Beat-Miss And Cautious AI Ad Outlook - Has The Bull Case Changed?

Why Tapestry (TPR) Shares Are Getting Obliterated Today

Why Tapestry (TPR) Shares Are Getting Obliterated Today What Happened? Shares of luxury fashion conglomerate Tapestry (NYSE:TPR) fell 14.8% in the morning session after the luxury fashion company issued a disappointing fiscal 2027 revenue forecast that triggered a steep selloff, completely overshadowing its fourth-quarter …

AdaptHealth (NASDAQ:AHCO) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen has downgraded AdaptHealth (NASDAQ:AHCO) from a "hold" to a "sell" rating, despite the broader consensus of "Moderate Buy" among analysts with an average price target of $10.29. The company's shares opened at $5.81, near their 52-week low, and below their 50-day …

Should I buy Scribe Therapeutics Inc. (SCTX)

ETFs Investing in Pinnacle West Capital Corp Stocks

This article lists Exchange Traded Funds (ETFs) that hold shares of Pinnacle West Capital Corp (PNW). It provides a detailed table including each fund's market value, weight of PNW in its holdings, issuer, management style, expense ratio, assets under management (AUM), price, and 3-year …

Maui Land & Pineapple (MLP) Stock Premium Clashes With Deepening Losses

Price-Driven Insight from (ZVRA) for Rule-Based Strategy

This article provides a price-driven analysis for Zevra Therapeutics Inc. (NASDAQ: ZVRA), highlighting weak near-term sentiment but strong mid and long-term outlooks. It details institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis, and an exceptional risk-reward short …

Arcutis (ARQT) Q2 2026 Earnings Call Transcript

Tapestry (TPR) Could Be 23% Undervalued After Profit Return And Cautious 2027 Outlook

Nektar Therapeutics (NKTR) Stock Slides As Cash Burn Clouds Pipeline Progress

Nektar Therapeutics' stock fell 4% following its Q2 2026 earnings report, despite progress in its autoimmune pipeline, notably rezpegaldesleukin. The market reacted negatively to the company's substantial cash burn, with a quarterly net loss exceeding US$40 million and trailing 12-month losses widening. While the …

Do Strong Q2 Results And Extra Dividends Change The Bull Case For Main Street Capital (MAIN)?

Main Street Capital (MAIN) reported strong Q2 2026 results with significant revenue and net income, alongside approving regular monthly dividends and a supplemental cash dividend. These developments, coupled with an at-the-market equity offering, reinforce the company's commitment to shareholder returns and funding its investment …

Will AIT’s Rising Earnings And M&A Firepower Redefine Applied Industrial Technologies' (AIT) Narrative

BlackRock ESG Capital Allocation Term Trust Revenue Breakdown – NYSE:ECAT

This page provides financial information for the BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) on TradingView. It offers an overview of the trust's financials, including statements, statistics, dividends, earnings, and segment performance. The content is primarily a data placeholder, indicating where detailed revenue …

How Rapport Therapeutics Inc. (RAPP) Affects Rotational Strategy Timing

This article analyzes Rapport Therapeutics Inc. (RAPP) using AI models to determine its effect on rotational strategy timing. Key findings suggest a strong sentiment supporting an overweight bias, with resistance being tested. The analysis provides specific institutional trading strategies, including position trading, momentum breakout, …

Brookstone Growth Stock ETF's Apple Inc(AAPL) Holding History

This article details Brookstone Growth Stock ETF's historical holdings of Apple Inc (AAPL) stock. As of May 31, 2026, the ETF held 19,314 shares of AAPL, valued at $6.03 million, representing 4.34% of its portfolio. The ETF initiated its AAPL position in Q4 2023 …

AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Edelson Lechtzin LLP, a national class action law firm, is investigating a data breach at AdaptHealth Corp. that exposed patient data. The breach, disclosed on July 2, 2026, involved a social engineering attack that compromised a third-party contractor's credentials, leading to unauthorized access to …

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) reported a Q2 loss of $0.31 per share, which was better than the Zacks Consensus Estimate of a $0.42 loss. However, the company missed revenue estimates, posting $5.15 million against an expected $5.43 million. Despite beating EPS estimates two out …

Jim Cramer Said Domino’s Was Better Than Papa John’s International, Inc. (NASDAQ:PZZA) – But Is He Right?

Pizza chain Papa John's International, Inc. (NASDAQ:PZZA)'s shares are down by 49% over the past year and by 39% year-to-date. On the 6th, the shares closed a whopping 17.8% lower. The dip occurred after Papa John's International, Inc. (NASDAQ:PZZA) reported its second quarter earnings …

Apollo Micro Systems Q1 Results: Defence Stock Reports 88% Revenue Growth, PAT Rises 43% YoY

How TG Therapeutics’ Q2 2026 Revenue Surge And Higher Guidance At TG Therapeutics (TGTX) Has Changed Its Investment Story

Should Record Results, 2027 Guidance, and M&A Push Require Action From Applied Industrial Technologies (AIT) Investors?

In August 2026, Applied Industrial Technologies reported record fourth-quarter and full-year results, with sales rising to US$1.35 billion for the quarter and US$4.97 billion for the year, alongside higher earnings per share versus the prior year. The company also issued fiscal 2027 guidance calling …

US Physical Therapy Appoints New Executive Vice President CFO

Q & M Dental Group (Singapore) (SGX:QC7) Stock Faces Rich P/E Despite Firmer Earnings

Zevra Therapeutics (ZVRA) insider files to resell RSU shares via broker

An insider at Zevra Therapeutics (ZVRA) has filed a Form 144 notice to resell up to 42,666 common shares. These shares are linked to restricted stock units granted in June 2025 and are planned for potential sale on NASDAQ. The filing also references previous …